UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

The Emerging Role of Phosphodiesterases in Movement Disorders

Erro, R; Mencacci, NE; Bhatia, KP; (2021) The Emerging Role of Phosphodiesterases in Movement Disorders. Movement Disorders 10.1002/mds.28686. (In press). Green open access

[thumbnail of Bhatia_The Emerging Role of Phosphodiesterases in Movement Disorders_AOP.pdf]
Preview
Text
Bhatia_The Emerging Role of Phosphodiesterases in Movement Disorders_AOP.pdf - Published Version

Download (549kB) | Preview

Abstract

Cyclic nucleotide phosphodiesterase (PDE) enzymes catalyze the hydrolysis and inactivation of the cyclic nucleotides cyclic adenosine monophosphate and cyclic guanosine monophosphate, which act as intracellular second messengers for many signal transduction pathways in the central nervous system. Several classes of PDE enzymes with specific tissue distributions and cyclic nucleotide selectivity are highly expressed in brain regions involved in cognitive and motor functions, which are known to be implicated in neurodegenerative diseases, such as Parkinson's disease and Huntington's disease. The indication that PDEs are intimately involved in the pathophysiology of different movement disorders further stems from recent discoveries that mutations in genes encoding different PDEs, including PDE2A, PDE8B, and PDE10A, are responsible for rare forms of monogenic parkinsonism and chorea. We here aim to provide a translational overview of the preclinical and clinical data on PDEs, the role of which is emerging in the field of movement disorders, offering a novel venue for a better understanding of their pathophysiology. Modulating cyclic nucleotide signaling, by either acting on their synthesis or on their degradation, represents a promising area for development of novel therapeutic approaches. The study of PDE mutations linked to monogenic movement disorders offers the opportunity of better understanding the role of PDEs in disease pathogenesis, a necessary step to successfully benefit the treatment of both hyperkinetic and hypokinetic movement disorders. © 2021 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.

Type: Article
Title: The Emerging Role of Phosphodiesterases in Movement Disorders
Location: United States
Open access status: An open access version is available from UCL Discovery
DOI: 10.1002/mds.28686
Publisher version: http://dx.doi.org/10.1002/mds.28686
Language: English
Additional information: © 2021 Published by Wiley. This is an open access article under the CC BY 4.0 license Attribution 4.0 International (https://creativecommons.org/licenses/by/4.0/)
Keywords: ADCY5, Huntington disease, PDE, adenylyl cyclases, cyclic nucleotides
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology > Clinical and Movement Neurosciences
URI: https://discovery.ucl.ac.uk/id/eprint/10130366
Downloads since deposit
94Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item